DoW, Ovarian Cancer, Ovarian Cancer Clinical Trial Academy - Early-Career Investigator Award
This grant funds early-career investigators within 12 years of training to conduct translational research or small early-phase clinical trials in ovarian cancer, with mentoring and at least 25% effort required.
Funder: Dept. of the Army -- USAMRAA
Due Dates: September 15, 2026: Pre-Application (Letter of Intent) | October 1, 2026: Full Application | October 6, 2026: End of Verification Period
Funding Amounts: Up to $1.4M total costs per award over 4 years; approx. 3 awards expected; $4.2M total program funding.
Summary: Supports early-career investigators in conducting translational and early-phase clinical trials in ovarian cancer, with intensive mentoring and career development in a national academy setting.
Key Information: Preliminary data required; ECI must be within 12 years of terminal training and commit ≥25% effort for first 2 years.
Description
This funding opportunity is designed to support the next generation of Early-Career Investigators (ECIs) in ovarian cancer clinical trial research. Through the Ovarian Cancer Clinical Trial Academy (OCCTA), awardees will receive funding, professional development, and intensive mentoring from established clinical trialists. The program aims to foster ECIs’ independence and expertise in designing and conducting translational research and small-scale, early-phase clinical trials focused on ovarian cancer. The Academy provides a collaborative environment with national networking, peer support, and structured career development activities.
